A polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice

References

• MellmanICoukosGDranoffGCancer immunotherapy comes of ageNature201148048048922193102
   PubMed Web of Science ®Google Scholar
• SongLYangMCKnoffJSunZYWuTCHungCFCancer immunotherapy using a potent immunodominant CTL epitopeVaccine201432466039604825245934
   PubMedGoogle Scholar
• MaedaHBharateGYDaruwallaJPolymeric drugs for efficient tumor-targeted drug delivery based on EPR-effectEur J Pharm Biopharm20097140941919070661
   PubMed Web of Science ®Google Scholar
• TorchilinVTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev20116313113520304019
   PubMed Web of Science ®Google Scholar
• KriegAMAntiinfective applications of Toll-like receptor 9 agonistsProc Am Thorac Soc20074328929417607015
   PubMedGoogle Scholar
• AskewDChuRSKriegAMHardingCVCpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHCII antigen-processing mechanismsJ Immunol20001656889689511120813
   PubMed Web of Science ®Google Scholar
• BehboudiSChaoDKlenermanPAustynJThe effects of DNA containing CpG motif on dendritic cellsImmunology20009936136610712665
   PubMedGoogle Scholar
• AntonyPAPiccirilloCAAkpinarliACD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cellsJ Immunol20051742591260115728465
   PubMed Web of Science ®Google Scholar
• ZoglmeierCBauerHNörenbergDCpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing miceClin Cancer Res2011171765177521233400
   PubMedGoogle Scholar
• ShirotaYShirotaHKlinmanDMIntratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cellsJ Immunol20121881592159922231700
   PubMed Web of Science ®Google Scholar
• AlshakerHAMatalkaKZIFN-g, IL-17 and TGF-b involvement in shaping the tumor microenvironment: the significance of modulating such cytokines in treating malignant solid tumorsCancer Cell Int201111334521943203
   PubMed Web of Science ®Google Scholar
• KanoMRBaeYIwataCImprovement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signalingProc Natl Acad U S A2007104934603465
   PubMed Web of Science ®Google Scholar
• OyanagiJKojimaNSatoHInhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factorExp Cell Res201432626727924780821
   PubMedGoogle Scholar
• GiannelliGVillaELahnMTransforming growth factor-β as a therapeutic target in hepatocellular carcinomaCancer Res20147471890189424638984
   PubMed Web of Science ®Google Scholar
• BholaNEBalkoJMDuggerTCTGF-β inhibition enhances chemotherapy action against triple-negative breast cancerJ Clin Invest201312331348135823391723
   PubMed Web of Science ®Google Scholar
• ChenMLPittetMJGorelikLRegulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoProc Natl Acad Sci U S A2005102241942415623559
   PubMed Web of Science ®Google Scholar
• WhartonKDerynckRTGF-β family signaling: novel insights in development and diseaseDevelopment2009136223691369719855012
   PubMedGoogle Scholar
• BandyopadhyayAAgyinJKWangLInhibition of pulmonary and skeletal metastasis by a transforming growth factor-β type I receptor kinase inhibitorCancer Res2006666714672116818646
   PubMed Web of Science ®Google Scholar
• XieJTengLYangZPolyethylenimine-linoleic acid conjugate for antisense oligonucleotide deliveryBioMed Res Int2013201317
   Google Scholar
• XieHYZuoCLiuYCell-targeting multifunctional nanospheres with both fluorescence and magnetismSmall2005150650917193476
   PubMed Web of Science ®Google Scholar
• SongEQWangGPXieHYVisual recognition and efficient isolation of apoptotic cells with fluorescent-magnetic-biotargeting multifunctional nanospheresClin Chem2007532177218517962366
   PubMedGoogle Scholar
• XieHYXieMZhangZLWheat germ agglutinin-modified trifunctional nanospheres for cell recognitionBioconjug Chem2007181749175517894449
   PubMed Web of Science ®Google Scholar
• HuJXieMWenCYA multicomponent recognition and separation system established via fluorescent, magnetic, dual-encoded multifunctional bioprobesBiomaterials2011321177118421071081
   PubMedGoogle Scholar
• SongEQHuJWenCYFluorescent-magnetic-biotargeting multifunctional nanobioprobes for detecting and isolating multiple types of tumor cellsACS Nano2011576177021250650
   PubMed Web of Science ®Google Scholar
• WenCYHuJZhangZLOne-step sensitive detection of Salmonella typhimurium by coupling magnetic capture and fluorescence identification with functional nanospheresAnal Chem20138521223123023256523
   PubMedGoogle Scholar
• HuJWenCYZhangZLOptically encoded multifunctional nanospheres for one-pot separation and detection of multiplex DNA sequencesAnal Chem201385119291193524191690
   PubMedGoogle Scholar
• HuJWenCYZhangZLXieMXieHYPangDWRecognition kinetics of biomolecules at the surface of different-sized spheresBiophys J201410716517324988351
   PubMedGoogle Scholar
• WenCYWuLLZhangZLQuick-response magnetic nanospheres for rapid, efficient capture and sensitive detection of circulating tumor cellsACS Nano2014894194924313365
   PubMedGoogle Scholar
• QuXFelderMAPerez HortaZSondelPMRakhmilevichALAntitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5-fluorouracil chemotherapy in the B16 melanoma modelInt Immunopharmacol20131741141114724201083
   PubMed Web of Science ®Google Scholar
• WangQSachsePSemmoMT- and B-cell responses and previous exposure to hepatitis B virus in ‘anti-HBc alone’ patientsJ Viral Hepat201522121068107826075501
   PubMedGoogle Scholar
• HanJLiangHYiJLong-term selenium-deficient diet induces liver damage by altering hepatocyte ultrastructure and MMP1/3 and TIMP1/3 expression in growing ratsBiol Trace Elem Res Epub2016624
   Google Scholar
• WeiMChenNLiJPolyvalent immunostimulatory nanoagents with self-assembled CpG oligonucleotide-conjugated gold nanoparticlesAngew Chem Int Ed Engl2012511202120622190176
   PubMed Web of Science ®Google Scholar
• WilsonKDde JongSDTamYKLipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacyAdv Drug Deliv Rev20096123324219232375
   PubMed Web of Science ®Google Scholar
• KuramotoYNishikawaMHyoudouKYamashitaFHashidaMInhibition of peritoneal dissemination of tumor cells by single dosing of phosphodiester CpG oligonucleotide/cationic liposome complexJ Control Release200611522623316996162
   PubMedGoogle Scholar
• KimDHMoonCOhSSLiposome-encapsulated CpG enhances antitumor activity accompanying the changing of lymphocyte populations in tumor via intratumoral administrationNucleic Acid Ther20152529510225692533
   PubMedGoogle Scholar
• de TittaABallesterMJulierZNanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low doseProc Natl Acad Sci U S A201311049199021990724248387
   PubMedGoogle Scholar
• BuhtoiarovINSondelPMWiggintonJMAnti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophagesImmunology201113222623921039467
   PubMedGoogle Scholar
• LonsdorfASKuekrekHSternBVBoehmBOLehmannPVTary-LehmannMIntratumor CpG-oligodeoxynucleotide injection induces protective antitumor T cell immunityJ Immunol20031713941394614530311
   PubMed Web of Science ®Google Scholar
• BauerJAYeFMarshallCBRNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cellsBreast Cancer Res2010123R4120576088
   PubMedGoogle Scholar
• WangYDengBTangWLiuTShenXTGF-β1 secreted by hepatocellular carcinoma induces the expression of the foxp3 gene and suppresses antitumor immunity in the tumor microenvironmentDig Dis Sci20135861644165223361571
   PubMedGoogle Scholar
• ClarkeJMHurwitzHIUnderstanding and targeting resistance to anti-angiogenic therapiesJ Gastrointest Oncol20134325326323997938
   PubMedGoogle Scholar
• ZhangMLahnMHuberPETranslating the combination of TGF-β blockade and radiotherapy into clinical development in glioblastomaOncoimmunology20121694394523162765
   PubMed Web of Science ®Google Scholar
• MaluccioMSharmaVLagmanMTacrolimus enhances transforming growth factor-β1 expression and promotes tumor progressionTransplantation200376359760212923450
   PubMedGoogle Scholar
• HawinkelsLJTen DijkePExploring anti-TGF-β therapies in cancer and fibrosisGrowth Factors201129414015221718111
   PubMed Web of Science ®Google Scholar